Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone
Authors
Keywords
-
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 46, Issue 8, Pages 713-721
Publisher
Springer Science and Business Media LLC
Online
2023-09-20
DOI
10.1007/s12272-023-01462-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
- (2023) Pureum Kang et al. ARCHIVES OF PHARMACAL RESEARCH
- Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes
- (2022) Choong-Min Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes
- (2022) Sang-Sup Whang et al. ARCHIVES OF PHARMACAL RESEARCH
- Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone
- (2022) Chang‑Keun Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects
- (2022) Chang‑Keun Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism
- (2021) Young-Hoon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients
- (2021) Eui Hyun Jung et al. ARCHIVES OF PHARMACAL RESEARCH
- Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects
- (2021) Nam-Tae Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes
- (2021) Chang‑Keun Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele
- (2021) Chang‑Keun Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes
- (2018) Ji-Young Byeon et al. ARCHIVES OF PHARMACAL RESEARCH
- Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine
- (2017) Niloufar Marsousi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Acute toxicity profile of tolperisone in overdose: Observational poison centre-based study
- (2015) Viktor Martos et al. CLINICAL TOXICOLOGY
- Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers
- (2015) M. Pawlowska et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- PP124—Pharmacokinetics of tolperisone in relation to CYP2C19 genotypes
- (2013) J.-Y. Byeon et al. CLINICAL THERAPEUTICS
- Effects of CYP2C19 Genetic Polymorphisms on Atomoxetine Pharmacokinetics
- (2013) Chang-Ik Choi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Partnering for Therapeutics Discovery
- (2012) C M Colvis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Allele and Genotype Frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese Populations
- (2012) Liang Jin Zuo et al. Genetic Testing and Molecular Biomarkers
- Effects of CYP2C9*1/*3 and *1/*13 on the pharmacokinetics of losartan and its active metabolite E-3174
- (2012) Jung-Woo Bae et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Determination of tolperisone in human plasma by liquid chromatography/tandem mass spectrometry for clinical application
- (2012) Chang-Ik Choi et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Tamsulosin Exposure Is Significantly Increased by theCYP2D6*10/*10Genotype
- (2012) Chang-Ik Choi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
- (2010) Jung-Woo Bae et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of CYP2C9*3 allele on the pharmacokinetics of naproxen in Korean subjects
- (2009) Jung-Woo Bae et al. ARCHIVES OF PHARMACAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started